STOCK RESEARCH AI Institutional Equity Engine
ZERO-HALLUCINATION DATA INTEGRITY • SEBI NON-ADVISORY SAFE HARBOR

Institutional Equity Research Engine
Grounded in Public Exchange Filings

Automated 7-pillar qualitative thesis synthesis, multi-scenario valuations, and quarterly drift surveillance for Indian equities. Built for discerning long-term investors and analysts.

Trending Dossiers: INFY TCS RELIANCE RAILTEL HDFCBANK TATASTEEL
151+
Verified Institutional Dossiers
100%
Zero-Hallucination Exchange Quotes
01–07
Core Forensic Diagnostic Checks
₹0.00
Free Archival Reads & Exchange Quotes
Analytical Framework

The 7-Check Institutional Health Matrix

Every equity dossier is synthesized across 7 rigorous strategic dimensions grounded directly in verified BSE regulatory filings and financial disclosures.

01. Business Model & Moat

Evaluates pricing power, switching costs, network effects, and durability against low-cost disruptors.

02. Capital Allocation

Audits ROCE, ROE, reinvestment rates, dividend policy, and management stewardship of shareholder funds.

03. Financial Health & Solvency

Debt-to-equity ratios, interest coverage cushions, operating cash flow quality, and working capital traps.

🌱

04. Growth Drivers & Industry

Total addressable market (TAM), sectoral tailwinds, regulatory barriers to entry, and volume visibility.

🏷️

05. Valuation & Margin of Safety

Trailing & Forward P/E multiples, EV/EBITDA bands, multi-scenario DCF estimates, and historical quartiles.

📈

06. Technicals & Momentum

52-week price range percentiles, 50-DMA trend lines, relative volume expansion, and moving averages.

07. Governance & Forensic Cleanliness

Related party transactions, promoter share pledging, auditor qualification records, and insider SAST filings.

📅 YESTERDAY'S 9:00 AM EDITION • INSTITUTIONAL QUALITY SURVEILLANCE

Stock Discovery @9AM

Curated and released daily at 9:00 AM IST from verified BSE exchange filings. High-ROCE, conservative leverage companies across varied sectors operating under institutional sell-side radar.

Explore All 15 Equities →
Healthcare & API/CRAMS Emerging Mid-Cap
NEULANDLAB ₹20,879.85
Neuland Laboratories Ltd
ROCE
27.6%
D/E
0.15x
P/E
54.02
Custom synthesis drug intermediate manufacturer experiencing gross margin expansion on proprietary molecule commercialization.
Inspect Full Dossier →
Specialty Chemicals Small-Cap
CLEAN ₹796.00
Clean Science and Technology Ltd
ROCE
31.2%
D/E
0.0x
P/E
36.50
Catalytic green-chemistry manufacturer commanding 40%+ operating margins with negative net debt and zero broker sell-side hype.
Inspect Full Dossier →
Specialty Chemicals Small-Cap
FINEORG ₹5,421.85
Fine Organic Industries Ltd
ROCE
26.4%
D/E
0.01x
P/E
38.04
Global leader in oleochemical green additives with zero debt and consistent 25%+ ROCE, operating under the institutional radar.
Inspect Full Dossier →
Industrial Machinery Small-Cap
WENDT ₹7,754.55
Wendt (India) Ltd
ROCE
32.1%
D/E
0.0x
P/E
91.61
High-precision superabrasives and grinding technology leader with 30%+ ROCE and substantial multi-year parentage support.
Inspect Full Dossier →
Renewables & Power Infra Small-Cap
KPIGREEN ₹325.25
KPI Green Energy Ltd
ROCE
22.4%
D/E
0.58x
P/E
14.08
Independent solar-wind hybrid power producer with growing captive consumer base and aggressive capacity commissioning.
Inspect Full Dossier →
EMS & Defence Electronics Emerging Mid-Cap
KAYNES ₹3,261.05
Kaynes Technology India Ltd
ROCE
18.2%
D/E
0.28x
P/E
63.48
High-complexity PCB & cleanroom electronics player expanding into OSAT packaging with a multi-year order pipeline.
Inspect Full Dossier →
Public Research Repository

Explore Verified Equities

100% free and open access to existing archived institutional dossiers. Read, inspect 7-pillar scorecards, and download official PDF reports.

FIEMIND 1 revs
Fiem Industries Ltd
Last Evaluated: 13-10-2026 21:40 IST
View Full Dossier →
ROSSARI 2 revs
Rossari Biotech Ltd
Last Evaluated: 13-10-2026 21:39 IST
View Full Dossier →
CUPID 1 revs
Cupid Ltd-$
Last Evaluated: 13-10-2026 20:42 IST
View Full Dossier →
ACE 1 revs
Action Construction Equipment Ltd
Last Evaluated: 12-10-2026 20:59 IST
View Full Dossier →
MARKSANS 1 revs
Marksans Pharma Ltd
Last Evaluated: 12-10-2026 20:58 IST
View Full Dossier →
CRAFTSMAN 1 revs
Craftsman Automation Ltd
Last Evaluated: 12-10-2026 20:57 IST
View Full Dossier →
DATAPATTNS 2 revs
Data Patterns (India) Ltd
Last Evaluated: 12-10-2026 20:55 IST
View Full Dossier →
TESTCORP 1 revs
Test Diagnostics Corp
Last Evaluated: 11-10-2026 11:52 IST
View Full Dossier →
SONACOMS 1 revs
Sona BLW Precision Forgings Ltd
Last Evaluated: 10-10-2026 09:01 IST
View Full Dossier →
Browse All 143 Institutional Equities & Screener →
Transparent Monetization

Research Credits & Subscriptions

On-demand compute credits power live AI syntheses grounded in real-time BSE filings. All existing archives, quotes, and PDF downloads remain 100% free.

Single Research Pass
₹299
1 Full Research Credit

Deep-dive into any single BSE/NSE equity with full AI reasoning.

  • 1 Full 7-Pillar AI Synthesis
  • Multi-Scenario DCF Valuation
  • Institutional PDF Report Export
  • Regulatory Exchange Citations
  • Never expires
Most Popular Analyst 3-Pack
₹699
3 Research Credits (₹233/stock)

Ideal for evaluating peer contenders and comparing top 3 industry leaders.

  • 3 Full 7-Pillar Syntheses
  • Surgical Price & Announcement Refreshes
  • Multi-Quarter Thesis Drift Surveillance
  • Unlimited PDF Downloads
  • Never expires
Portfolio 10-Pack
₹1,799
10 Research Credits (₹180/stock)

Comprehensive institutional audit for an entire equity portfolio.

  • 10 Full 7-Pillar Syntheses
  • 10 Watched Tickers in Surveillance
  • Priority AI Processing Pipeline
  • Differential Analysis Audits
  • Never expires
Pro Desk (Monthly)
₹999 /month
⭐ 40 Syntheses / mo

Continuous surveillance engine for full-time investors and advisors.

  • 40 Fresh Syntheses / month
  • Unlimited Surgical Updates (0 credits)
  • 50 Watched Equities in Surveillance
  • Unlimited PDF Exports
  • Cancel anytime